Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 8518631, 6 pages
https://doi.org/10.1155/2018/8518631
Clinical Study

Cognitive Behavior Therapy as Augmentation for Sertraline in Treating Patients with Persistent Postural-Perceptual Dizziness

1Department of Emergency, Yongchuan Hospital of Chongqing Medical University, Chongqing, China
2Department of Neurology, Baotou Central Hospital, Inner Mongolia, China
3Qinggang Senior Care Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
4Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Correspondence should be addressed to Jiying Zhou; moc.361@ehcadaehz

Received 29 December 2017; Revised 29 January 2018; Accepted 8 February 2018; Published 7 March 2018

Academic Editor: Luca Prosperini

Copyright © 2018 Yi-Chuan Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. P. Staab, A. Eckhardt-Henn, A. Horii et al., “Diagnostic criteria for persistent postural-perceptual dizziness (PPPD): consensus document of the committee for the classification of vestibular disorders of the bárány society,” Journal of Vestibular Research: Equilibrium & Orientation, vol. 27, no. 4, pp. 191–208, 2017. View at Publisher · View at Google Scholar
  2. J. Yi and Z. Xing-quan, “Chronic Subjective Dizziness,” Chinese Journal of Stroke, vol. 8, no. 5, pp. 388–392, 2013. View at Google Scholar
  3. J. I. Benitoorejas, Chronic subjective dizziness. Revista De La Sociedad Otorrinolaringológica De Castilla Y León Cantabria Y La Rioja, vol. 4, 2013, pp. 13-19.
  4. J. P. Staab and M. J. Ruckenstein, “Expanding the differential diagnosis of chronic dizziness,” Archives of Otolaryngology—Head and Neck Surgery, vol. 133, no. 2, pp. 170–176, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Ödman and R. Maire, “Chronic subjective dizziness,” Acta Oto-Laryngologica, vol. 128, no. 10, pp. 1085–1088, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. J. P. Staab, M. J. Ruckenstein, D. Solomon, and N. T. Shepard, “Serotonin reuptake inhibitors for dizziness with psychiatric symptoms,” Archives of Otolaryngology—Head and Neck Surgery, vol. 128, no. 5, pp. 554–560, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. J. P. Staab and M. J. Ruckenstein, “Chronic dizziness and anxiety: Effect of course of illness on treatment outcome,” JAMA Otolaryngology–Head & Neck Surgery, vol. 131, no. 8, pp. 675–679, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Goto, T. Tsutsumi, and K. Ogawa, “Treatment of chronic subjective dizziness by SSRIs,” Journal of Otolaryngology of Japan, vol. 116, no. 11, pp. 1208–1213, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. J. P. Staab, “Chronic subjective dizziness,” Continuum: Lifelong Learning in Neurology, vol. 18, no. 5, pp. 1118–1141, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Meli, G. Zimatore, C. Badaracco, E. De Angelis, and D. Tufarelli, “Effects of vestibular rehabilitation therapy on emotional aspects in chronic vestibular patients,” Journal of Psychosomatic Research, vol. 63, no. 2, pp. 185–190, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Ye and L. Hong-jing, “Liu Hong-jing. The efficacy of biofeedback behavioral cognitive and vestibular rehabilitation treatment on patients with chronic subjective dizziness,” Chinese Journal of Behavioral Medicine and Brain Science, vol. 26, no. 2, pp. 139–142, 2017. View at Google Scholar
  12. L. Yardley, F. Barker, I. Muller et al., “Clinical and cost effectiveness of booklet based vestibular rehabilitation for chronic dizziness in primary care: Single blind, parallel group, pragmatic, randomised controlled trial,” BMJ, vol. 344, no. 7860, Article ID e2237, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Holmberg, M. Karlberg, U. Harlacher, and M. Magnusson, “One-year follow-up of cognitive behavioral therapy for phobic postural vertigo,” Journal of Neurology, vol. 254, no. 9, pp. 1189–1192, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Edelman, A. E. J. Mahoney, and P. D. Cremer, “Cognitive behavior therapy for chronic subjective dizziness: A randomized, controlled trial,” American Journal of Otolaryngology - Head and Neck Medicine and Surgery, vol. 33, no. 4, pp. 395–401, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. Li. Jian, Q. Yi-ping, W. Xiu-zhen, and W. Jian-wen, “Paroxetine, cognitive-behavioral therapy, and their combination in mild depression,” Shanghai Archives of Psychiatry, vol. 20, no. 6, pp. 342–345, 2008. View at Google Scholar
  16. C. Da-qun, “Comparable research between cognitive behavior therapy and drug therapy on patients with anxiety,” Chongqing Medicine, vol. 38, no. 7, pp. 775-776, 2009. View at Google Scholar
  17. J. T. Walkup, A. M. Albano, J. Piacentini et al., “Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety,” The New England Journal of Medicine, vol. 359, no. 26, pp. 2753–2766, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Yingjie, L. Ya-nan, G. Ying-jun, and X. Qian, Wang Bing-jie, Kong Gui-liang. Efficacy of Flupentixol and Melitracen Tablets Combined with Dexzopiclone in the Treatment of Chronic Tension- type Headache with Depression, Anxiety and Insomnia. Chinese General Practice, vol. 6, 864-866, 6, 2013.
  19. J.-J. Chen, C.-J. Zhou, P. Zheng et al., “Differential urinary metabolites related with the severity of major depressive disorder,” Behavioural Brain Research, vol. 332, pp. 280–287, 2017. View at Publisher · View at Google Scholar · View at Scopus
  20. G. P. Jacobson and C. W. Newman, “The development of the Dizziness Handicap Inventory,” JAMA Otolaryngology–Head & Neck Surgery, vol. 116, no. 4, pp. 424–427, 1990. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Cipriani, T. A. Furukawa, G. Salanti et al., “Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis,” The Lancet, vol. 373, no. 9665, pp. 746–758, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Jain, M. H. Trivedi, A. J. Rush et al., “Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST),” Contemporary Clinical Trials, vol. 34, no. 1, pp. 136–144, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. A. H. Glassman, C. M. O'Connor, R. M. Califf et al., “Sertraline treatment of major depression in patients with acute MI or unstable angina,” The Journal of the American Medical Association, vol. 288, no. 6, pp. 701–709, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. S. S. Hedayati, L. P. Gregg, T. Carmody et al., “Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence,” Journal of the American Medical Association, vol. 318, no. 19, p. 1876, 2017. View at Publisher · View at Google Scholar
  25. T. A. Field, E. T. Beeson, and L. K. Jones, “The New ABCs: A Practitioner's Guide to Neuroscience-Informed Cognitive-Behavior Therapy,” Journal of Mental Health Counseling, vol. 37, no. 3, pp. 206–220, 2015. View at Publisher · View at Google Scholar
  26. C. L. Benjamin, C. M. Puleo, C. A. Settipani et al., “History of Cognitive-Behavioral Therapy in Youth,” Child and Adolescent Psychiatric Clinics of North America, vol. 20, no. 2, pp. 179–189, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. J.-J. Chen, B.-H. Zeng, W.-W. Li et al., “Effects of gut microbiota on the microRNA and mRNA expression in the hippocampus of mice,” Behavioural Brain Research, vol. 322, pp. 34–41, 2017. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Ménard, G. E. Hodes, and S. J. Russo, “Pathogenesis of depression: Insights from human and rodent studies,” Neuroscience, vol. 321, pp. 138–162, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Tian-yi, Z. Cao-bing, C. Xiao-ping, and T. Chao-lang, “Use of escitalopram for treatment of chronic subjective dizziness: a report of 32 cases,” Herald of Medicine, vol. 35, no. 3, pp. 272–275, 2016. View at Google Scholar